购物车
- 全部删除
- 您的购物车当前为空
Meropenem (SM 7338) 是一种具有广谱抗菌活性的碳青霉烯抗生素,对敏感和耐药的淋病奈瑟氏球菌,流感嗜血杆菌和杜克氏杆菌的 MIC 值分别为 0.02-0.06 mg/mL,0.03-0.12 mg/mL 和 0.015-0.12 mg/mL。
Meropenem (SM 7338) 是一种具有广谱抗菌活性的碳青霉烯抗生素,对敏感和耐药的淋病奈瑟氏球菌,流感嗜血杆菌和杜克氏杆菌的 MIC 值分别为 0.02-0.06 mg/mL,0.03-0.12 mg/mL 和 0.015-0.12 mg/mL。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 292 | 现货 | |
50 mg | ¥ 418 | 现货 | |
100 mg | ¥ 587 | 现货 | |
500 mg | ¥ 1,449 | 现货 |
产品描述 | Meropenem (SM 7338) is a carbapenem antibiotic with broad spectrum of activity that is administered intravenously and used for severe bacterial infections due to sensitive agents. Meropenem is a common cause of mild transient aminotransferase elevations and can rarely result in clinically apparent, cholestatic liver injury. |
体外活性 | Meropenem明显提高兔体内丙戊酸-葡萄糖醛酸在尿中的排泄. |
体内活性 | Meropenem具有类似于亚胺培南的抗菌谱,但对葡萄状球菌和肠球菌的活性略低,它对绿脓杆菌、所有的肠杆菌科和流感嗜血杆菌具有更强的活性。Meropenem对革兰氏阴性生物体的抗微生物活性是亚胺培南的两到四倍,其抗菌谱比测试的所有其他药物更宽。Meropenem与其他几个β-内酰胺类抗株产I型头孢菌素有拮抗效应。Meropenem最强烈地结合大肠杆菌和绿脓杆菌的青霉素结合蛋白2和金黄色葡萄球菌的青霉素结合蛋白1。 |
激酶实验 | Complementation of SCR7 Inhibition with Puri?ed Ligase IV: Complementation experiment is carried out by adding increasing concentrations of puri?ed Ligase IV/XRCC4 complex (30, 60, and 120 fmol) along with the oligomeric DNA substrates (5' compatible and 5'-5' noncompatible ends) to the SCR7-treatedextracts. Reactions are incubated for 2 h at 25℃. The reaction products are then resolved on 8% denaturing PAGE. The gel is dried and exposed and the signal is detected with a PhosphorImager and analyzed with Multi Gauge (V3.0) software. |
别名 | SM 7338, 美罗培南 |
分子量 | 383.46 |
分子式 | C17H25N3O5S |
CAS No. | 96036-03-2 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 100 mg/mL (260.78 mM), Sonication is recommended. Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: 5 mg/mL (13.04 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.